StaurosporineAlternative Names: AM 2282
Latest Information Update: 26 Jul 2001
At a glance
- Originator Asahi Kasei
- Class Alkaloids; Anorectics; Antifungals; Antineoplastics; Antiplatelets; Carbazoles
- Mechanism of Action Platelet aggregation inhibitors; Protein kinase A inhibitors; Protein kinase C inhibitors; Protein kinase G inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Arrhythmias; Cancer; Hypertension; Thrombosis